Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) does affect how your body uses energy, but calling it a simple metabolism booster oversimplifies what it actually does. The medicine works mainly by reducing appetite and slowing how quickly the stomach empties, which together drive meaningful weight loss — but its relationship with metabolic rate is more nuanced than that headline suggests. These are prescription-only medicines assessed by a clinician before any prescription is issued.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people asking whether tirzepatide increases metabolism are really asking one of two things: will it help me burn more calories at rest, or does it do something beyond just making me eat less? Both are fair questions, and the honest answer to each is different.
Resting metabolic rate (the calories your body burns to keep you alive while you're sitting still) is largely set by how much lean tissue you carry. As you lose weight, that rate tends to fall. It's one reason weight loss often slows over time, regardless of the method. Mounjaro doesn't appear to directly rev up resting energy expenditure in the way a stimulant might. What it does instead is more interesting: by activating both GIP and GLP-1 receptors, it reshapes how the body partitions energy. GIP receptor activation in particular influences fat-cell metabolism and insulin sensitivity in ways that a GLP-1-only medicine doesn't replicate. Early research suggests this dual action may help preserve lean muscle mass during weight loss, which in turn helps protect the metabolic rate that would otherwise drop. That's not the same as raising metabolism, but it's a meaningful distinction, losing fat without losing muscle keeps your engine running more efficiently as the weight comes off.
The NHS tirzepatide medicines page explains the dual-receptor mechanism and its effects on appetite and blood sugar, which sit alongside the energy-balance effects described here.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed thousands of adults over 72 weeks and found average body-weight reductions of around 20–21% at the 15mg dose. What that headline figure doesn't capture is where the weight came from. Sub-studies and body-composition analyses from the tirzepatide programme found that most of the weight lost was fat mass, with lean mass largely preserved, a pattern that distinguishes tirzepatide from some earlier weight-loss approaches where muscle loss was more pronounced.
Preserving lean mass matters metabolically. Muscle is the body's main calorie-burning tissue at rest. If you lose ten kilograms but retain most of your muscle, your resting metabolic rate falls less sharply than if you lost the same weight with significant muscle loss alongside it. That's one plausible mechanism by which tirzepatide could have a more favourable metabolic profile over time, not by actively increasing metabolism, but by blunting the metabolic slowdown that weight loss typically produces.
There is also evidence that GLP-1 receptor activation can influence energy expenditure modestly through central nervous system pathways, though the size of this effect in humans and its clinical significance is still being studied. Some people also ask whether treatment affects other areas of wellbeing, and if you're curious about whether Mounjaro has any effect on libido, that page looks at what the current evidence suggests. Anyone considering Mounjaro for weight management should treat the body-composition benefits as a secondary advantage of clinical-grade treatment, not a guaranteed metabolic upgrade.
The metabolic effects of tirzepatide are not fixed from the first injection. Treatment starts at 2.5mg, that first pen's job is to let your system adjust, not to deliver maximum therapeutic effect. The dose rises in steps, typically every four weeks, guided by your prescriber. The body-composition and appetite effects that drive the metabolic picture build gradually as the dose increases through the Mounjaro titration schedule.
This is why questions about metabolism and tirzepatide can't be cleanly separated from questions about dosing. Understanding whether raising your dose affects weight loss outcomes or why dose increases are planned the way they are gives you the fuller picture. At 5mg, for example, appetite suppression is more noticeable than at 2.5mg; fat-mass loss accumulates over the months that follow. The metabolic changes aren't a switch that flips, they're the cumulative result of consistent treatment, dietary changes and physical activity running alongside each other.
What you eat on treatment matters here too. Adequate protein intake supports lean mass retention, which supports the metabolic floor. A prescriber can point you toward the right support; the specific targets depend on your starting point and progress. For a grounded overview of the full weight-loss treatment landscape, including how lifestyle changes sit alongside medication, that page covers the context well.
If your decision to explore tirzepatide rests partly on whether it will help your metabolism recover after years of yo-yo dieting or a significant period of weight gain, the evidence is cautiously encouraging, but it's evidence for a clinical treatment, not a metabolic accelerator you can take in isolation. The medicine does appear to support fat-preferential weight loss and may blunt the metabolic slowdown that accompanies weight loss. It does not simply speed up your metabolism in the way that phrase is often imagined.
Mounjaro is a prescription-only medicine. A clinician reviews your health history, current medications, BMI and any weight-related conditions before any prescription is written, a prescriber reads your consultation, not software. If you'd like that assessment, you can start your free consultation with our team. Once approved as clinically suitable, the pen arrives via tracked DPD delivery the next working day, in plain packaging, with the full clinical support our team provides through aftercare.
Our clinical team can also answer questions specific to your situation through the aftercare service. For more on how dose adjustments are timed in practice, the guidance on when to increase dose is worth reading alongside this page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.